Company intelligence / Profile preview
Patrys Limited
Melbourne, Victoria, Australiapatrys.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Patrys has developed a pipeline of natural human antibody therapies for oncology and inflammatory disease. Its lead programs have demonstrated safety and some efficacy signals in early-phase trials. For example, PAT-SC1 showed a ten-year survival benefit in treated gastric cancer patients. PAT-SM6 completed a Phase I/IIa trial in relapsed/refractory multiple myeloma with no significant adverse events and evidence of stable disease in some patients at day +36 post-treatment. The company continues to advance its pipeline through internal development and partnerships.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Natural human antibodies (including deoxymabs)Monoclonal antibodies (mAbs)
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
Onyx Pharmaceuticals / Amgen Inc. sponsoring combination trial for PAT-SM6 in multiple myeloma
Beyond the preview
Go deeper on Patrys Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Patrys Limited.